Insights

HOCl Growth leverage their HOCl-based wound care and dermatology portfolio to expand into hospital systems, long-term care facilities, and retail dermatology aisles with starter packs and patient education materials to drive trial and adoption.

Dermatology Expansion capitalize on the recent dermatology product line launch under Aquanil to pursue collaborations with dermatology clinics, estheticians, and skincare retailers targeting sensitive skin and post-procedure care.

RetailFootprint expand presence in national retailers following U.S. CVS and Walmart launches by offering exclusive bundles, coupons, and cross-sell opportunities with wound care, diaper rash, and acne lines.

RegulatoryLeader leverage new SVP Regulatory and Product Development appointment to pursue regulatory-aligned SKUs, faster market access, and private-label discussions with health systems seeking compliant HOCl solutions.

GlobalMarkets target international expansion, building on UK acne line success to explore partnerships in EU, APAC, and LATAM with distribution agreements and localized formulations for wound, dermatology, and eye/oral care avenues.

Similar companies to Sonoma Pharmaceuticals

Sonoma Pharmaceuticals Tech Stack

Sonoma Pharmaceuticals uses 8 technology products and services including Amazon Web Services, WordPress, MySQL, and more. Explore Sonoma Pharmaceuticals's tech stack below.

Media & News

Sonoma Pharmaceuticals's Email Address Formats

Sonoma Pharmaceuticals uses at least 1 format(s):
Sonoma Pharmaceuticals Email FormatsExamplePercentage
FLast@sonomapharma.comJDoe@sonomapharma.com
95%
F.Last@sonomapharma.comJ.Doe@sonomapharma.com
3%
FirstLast@sonomapharma.comJohnDoe@sonomapharma.com
2%

Frequently Asked Questions

What is Sonoma Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Sonoma Pharmaceuticals is a publicly traded company; the company's stock symbol is SNOA.

What is Sonoma Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Sonoma Pharmaceuticals's official website is sonomapharma.com and has social profiles on LinkedInCrunchbase.

How much revenue does Sonoma Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of August 2026, Sonoma Pharmaceuticals's annual revenue is estimated to be $10M - $25M.

What is Sonoma Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Sonoma Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sonoma Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of August 2026, Sonoma Pharmaceuticals has approximately 23 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer And General Counsel: A. T.Chief Operating Officer: M. U.Owner: C. V.. Explore Sonoma Pharmaceuticals's employee directory with LeadIQ.

What industry does Sonoma Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Sonoma Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Sonoma Pharmaceuticals use?

Minus sign iconPlus sign icon
Sonoma Pharmaceuticals's tech stack includes Amazon Web ServicesWordPressMySQLWooCommerceMailchimpMicrosoft 365Google Fonts APIApache.

What is Sonoma Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Sonoma Pharmaceuticals's email format typically follows the pattern of FLast@sonomapharma.com. Find more Sonoma Pharmaceuticals email formats with LeadIQ.

How much funding has Sonoma Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of August 2026, Sonoma Pharmaceuticals has raised $85M in funding. The last funding round occurred on Apr 24, 2026 for $2.7M.
Sonoma Pharmaceuticals logo

Sonoma Pharmaceuticals

Pharmaceutical ManufacturingColorado, United States11-50 Employees

Sonoma Pharmaceuticals, based in Boulder, Colorado, is a relatively small pharmaceutical manufacturer focused on wound care and dermatology. The company develops and commercializes a range of products built on its patented Microcyn technology. With more than two decades of experience, Sonoma aims to improve patient outcomes by delivering reliable solutions that support wound healing and skin health. It collaborates with researchers and partners to bring products to market.

Its offerings target clinicians and consumers seeking safe, early-intervention relief for wounds and dermatological needs. In March 2026, the company announced the U.S. retail launch of an HOCl-based burn relief hydrogel in CVS and Walmart stores nationwide.

Section iconCompany Overview

Stock Symbol
SNOA
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
11-50

Section iconFunding & Financials

  • $85M

    Sonoma Pharmaceuticals has raised a total of $85M of funding over 6 rounds. Their latest funding round was raised on Apr 24, 2026 in the amount of $2.7Mas a post_ipo_equity.

  • $10M - $25M

    Sonoma Pharmaceuticals's revenue is estimated to be in the range of $10M - $25M

Section iconFunding & Financials

  • $85M

    Sonoma Pharmaceuticals has raised a total of $85M of funding over 6 rounds. Their latest funding round was raised on Apr 24, 2026 in the amount of $2.7Mas a post_ipo_equity.

  • $10M - $25M

    Sonoma Pharmaceuticals's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.